You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Metastases

Enzalutamide for treating hormone-sensitive metastatic prostate cancer

  • Technology appraisal guidance
  • Reference number: TA712
  • Published:  07 July 2021
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Resource impact
  2. Guidance into practice

Tools and resources

Tools to help you put the guidance into practice.

Resource impact

  • Resource impact report (PDF 255 KB)

    Published:
    07 July 2021
  • Resource impact template (Excel 1.39 MB)

    Published:
    07 July 2021

Guidance into practice

  • About the Into practice guide

  • Practical steps to improving the quality of care and services using NICE guidance

Back to top